Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Elanco, Ginkgo Bioworks Launch BiomEdit, Microbiome-Focused Animal Health Firm

ELAN Ginkgo NYSE DNA Ginkgo Bioworks Holdings Inc
  • Elanco Animal Health Incorporated (NYSE:ELAN) and Ginkgo Bioworks Holdings Inc (NYSE:DNA) have launched BiomEdit, a microbiome innovation company.
  • BiomEdit will discover, develop and introduce novel probiotics, bioactive molecules, engineered microbial medicines, and microbial monitoring services for animal health.
  • In October last year, Elanco announced its intention to carve out its microbiome platform and pipeline under the leadership of Aaron Schacht, BiomEdit CEO and former Elanco EVP of Innovation, Regulatory, and Business Development, to concentrate and focus more resources on its late-stage Pet Health pipeline. 
  • In addition to Elanco and Ginkgo's assets and intellectual property, BiomEdit is launching with a targeted Series A funding raise of $40 million, with participation by Viking Global Investors and Anterra Capital. 
  • In exchange for their respective asset and intellectual property contributions, Elanco and Ginkgo are expected to retain approximately 40% combined proportional ownership of BiomEdit.
  • Price Action: ELAN shares are down 0.27% at $26.18, and DNA stock is down 3.97% at $3.39 during the market session on the last check Monday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
How old is too old? I’m 77 and I don’t know yet. But I will when I get there
I get advice about my age on social media (not all of it friendly), but I’m sanguine about life without youthful anxieties, says Guardian columnist Polly Toynbee
The Guardian - UK
The Guardian - UK
Seth Meyers on campus unrest: ‘The story is what’s happening in Gaza’
Late-night hosts talk police crackdowns on pro-Palestinian protests, Trump’s court naps and Kristi Noem’s dogged defense
The Guardian - US
The Guardian - US
What happened to 7 Up? How 'The Uncola' faded into obscurity
Sprite has dominated the lemon-lime soft drink market in recent years — here’s what 7 Up, the “Uncola” maker, is doing to try to win back customers.
The Street
The Street
Decaf coffee might be banned in the U.S. (here's why)
The popular drink has been a morning and lunchtime staple for decades.
The Street
The Street
Scientists welcome new rules on marijuana, but research will still face obstacles
When marijuana becomes a Schedule III instead of a Schedule I substance under federal rules, researchers will face fewer barriers to studying it. But there will still be some roadblocks for science.
WEKU
WEKU
These 4 Netflix Is a Joke specials are available to watch at home
From John Mulaney to Kevin Hart, you can watch these Netflix Is a Joke specials even if you're not in Los Angeles.
WhatToWatch
WhatToWatch
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
Download on the AppStore Get it on Google Play